CCNP Award Paper: Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology
Background: Melatonin (MLT) is a pleiotropic neurohormone controlling many physiological
processes and whose dysfunction may contribute to several different diseases, such as …
processes and whose dysfunction may contribute to several different diseases, such as …
[HTML][HTML] Melatonin as a potential approach to anxiety treatment
Anxiety disorders are the most common mental diseases. Anxiety and the associated
physical symptoms may disturb social and occupational life and increase the risk of somatic …
physical symptoms may disturb social and occupational life and increase the risk of somatic …
Anatomical and cellular localization of melatonin MT1 and MT2 receptors in the adult rat brain
B Lacoste, D Angeloni… - Journal of pineal …, 2015 - Wiley Online Library
The involvement of melatonin in mammalian brain pathophysiology has received growing
interest, but information about the anatomical distribution of its two G‐protein‐coupled …
interest, but information about the anatomical distribution of its two G‐protein‐coupled …
[HTML][HTML] Antidepressant actions of melatonin and melatonin receptor agonist: Focus on pathophysiology and treatment
Y Wang, Y Jiang, M Zou, J Liu, H Zhao… - Behavioural brain research, 2022 - Elsevier
Depression has become one of the most commonly prevalent neuropsychiatric disorders,
and the main characteristics of depression are sleep disorders and melatonin secretion …
and the main characteristics of depression are sleep disorders and melatonin secretion …
Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action
MJ Millan - Therapeutic Advances in Psychopharmacology, 2022 - journals.sagepub.com
Generalized anxiety disorder (GAD), the most frequently diagnosed form of anxiety, is
usually treated by cognitive-behavioural approaches or medication; in particular …
usually treated by cognitive-behavioural approaches or medication; in particular …
Abnormal composition of gut microbiota contributes to delirium‐like behaviors after abdominal surgery in mice
J Zhang, JJ Bi, GJ Guo, L Yang, B Zhu… - CNS Neuroscience …, 2019 - Wiley Online Library
Aims Anesthesia and surgery can cause delirium‐like symptoms postoperatively. Increasing
evidence suggests that gut microbiota is a physiological regulator of the brain. Herein, we …
evidence suggests that gut microbiota is a physiological regulator of the brain. Herein, we …
[HTML][HTML] Melatoninergic system in Parkinson's disease: from neuroprotection to the management of motor and nonmotor symptoms
JM Mack, MG Schamne, TB Sampaio… - … medicine and cellular …, 2016 - hindawi.com
Melatonin is synthesized by several tissues besides the pineal gland, and beyond its
regulatory effects in light-dark cycle, melatonin is a hormone with neuroprotective, anti …
regulatory effects in light-dark cycle, melatonin is a hormone with neuroprotective, anti …
[HTML][HTML] Age-Related Effects of Exogenous Melatonin on Anxiety-like Behavior in C57/B6J Mice
S Nasini, S Tidei, A Shkodra, D De Gregorio… - Biomedicines, 2023 - mdpi.com
The synthesis of melatonin (MLT) physiologically decreases during aging. Treatment with
MLT has shown anxiolytic, hypnotic, and analgesic effects, but little is known about possible …
MLT has shown anxiolytic, hypnotic, and analgesic effects, but little is known about possible …
Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways
M Lopez-Canul, E Palazzo, S Dominguez-Lopez… - Pain, 2015 - journals.lww.com
Neuropathic pain is an important public health problem for which only a few treatments are
available. Preclinical studies show that melatonin (MLT), a neurohormone acting on MT1 …
available. Preclinical studies show that melatonin (MLT), a neurohormone acting on MT1 …
Potential functional and pathological side effects related to off-target pharmacological activity
JJ Lynch III, TR Van Vleet, SW Mittelstadt… - … of pharmacological and …, 2017 - Elsevier
Most pharmaceutical companies test their discovery-stage proprietary molecules in a battery
of in vitro pharmacology assays to try to determine off-target interactions. During all phases …
of in vitro pharmacology assays to try to determine off-target interactions. During all phases …